# Effect of Acetazolamide and Furosemide on Obesity-induced Glomerular Hyperfiltration

> **NCT01146288** · NA · COMPLETED · sponsor: **Rabin Medical Center** · enrollment: 13 (actual)

## Conditions studied

- Obesity-induced Hyperfiltration

## Interventions

- **DRUG:** Furosemide first, then Acetazolamide
- **DRUG:** Acetazolamide first, then Furosemide

## Key facts

- **NCT ID:** NCT01146288
- **Lead sponsor:** Rabin Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2015-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01146288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01146288, "Effect of Acetazolamide and Furosemide on Obesity-induced Glomerular Hyperfiltration". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01146288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*